Literature DB >> 1857411

Anti-HIV drug mechanism.

I M Jones, G S Jacob.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1857411     DOI： 10.1038/352198b0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease.

Authors:  F Salvatori; S Masiero; C Giaquinto; C M Wade; A J Brown; L Chieco-Bianchi; A De Rossi
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

2.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.

Authors:  R A Fouchier; M Groenink; N A Kootstra; M Tersmette; H G Huisman; F Miedema; H Schuitemaker
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Authors:  P B Fischer; M Collin; G B Karlsson; W James; T D Butters; S J Davis; S Gordon; R A Dwek; F M Platt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

4.  Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.

Authors:  E Fenouillet; I Jones; B Powell; D Schmitt; M P Kieny; J C Gluckman
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

5.  Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission.

Authors:  N Ahmad; B M Baroudy; R C Baker; C Chappey
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  Inhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cells.

Authors:  D L Taylor; M S Kang; T M Brennan; C G Bridges; P S Sunkara; A S Tyms
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

7.  N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.

Authors:  P B Fischer; G B Karlsson; T D Butters; R A Dwek; F M Platt
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomerase.

Authors:  Marie-Jeanne Papandréou; Rym Barbouche; Régis Guieu; Santiago Rivera; Jacques Fantini; Michel Khrestchatisky; Ian M Jones; Emmanuel Fenouillet
Journal:  J Biol Chem       Date:  2010-03-04       Impact factor: 5.157
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.